経カテーテル僧帽弁修復術（TMVR）の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、処置、予測（～2033年）

当レポートでは、世界の経カテーテル僧帽弁修復術（TMVR）市場について調査分析し、主要企業と市場シェア、主要動向、革新的な製品と技術、競合情勢などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの経カテーテル僧帽弁修復術（TMVR）の市場と進化する競合情勢

• 主な業界動向の考察
• 経カテーテル僧帽弁修復術（TMVR）市場のセグメント別の年間収益と市場見通し（2015年～2033年）
• セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 経カテーテル僧帽弁修復術（TMVR）市場のSWOT分析
• 経カテーテル僧帽弁修復術（TMVR）市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Abbott Laboratories
• Edwards Lifesciences Corp
• その他

Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR). Mitral regurgitation (MR), also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. There are two types of MR: degenerative (primary), and functional (secondary). In Europe, transcatheter mitral valve repair (TMVR) is indicated for both primary and secondary MR. Transcatheter Mitral Valve Repair (TMVR) is FDA approved for both primary and secondary MR. Mitral valve repair treatment is preferred over mitral valve replacement in eligible patients because it is linked with lower short-term and long-term mortality and morbidity rates.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Repair (TMVR) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Repair (TMVR) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Repair (TMVR) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Repair (TMVR) Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Repair (TMVR) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Repair (TMVR) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Repair (TMVR) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.